Illuminating breast cancer invasion: Diverse roles for cell-cell interactions

Current Opinion in Cell Biology

Volumn 30, Issue 1, 2014, Pages 99-111

  Cheung, Kevin J ^a   Ewald, Andrew J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BREAST TUMOR; CELL COMMUNICATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; METASTASIS; PATHOLOGY; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL COMMUNICATION; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84906051957     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2014.07.003     Document Type: Review

References (154)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Egeblad M., Nakasone E.S., Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Develop Cell 2010, 18:884-901.
3. Hunter K. Host genetics influence tumour metastasis. Nat Rev Cancer 2006, 6:141-146.
4. Nguyen D.X., Massague J. Genetic determinants of cancer metastasis. Nat Rev Genetics 2007, 8:341-352.
5. Coussens L.M., Pollard J.W. Leukocytes in mammary development and cancer. Cold Spring Harbor Persp Biol 2011, 3.
6. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012, 196:395-406.
7. Weigelt B., Bissell M.J. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008, 18:311-321.
8. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science (New York, NY) 2002, 296:1046-1049.
9. Gray R.S., Cheung K.J., Ewald A.J. Cellular mechanisms regulating epithelial morphogenesis and cancer invasion. Curr Opin Cell Biol 2010, 22:640-650.
10. Wellings S.R., Jensen H.M., Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975, 55:231-273.
11. Lerwill M.F. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004, 28:1076-1091.
12. Polyak K., Hu M. Do myoepithelial cells hold the key for breast tumor progression?. J Mamm Gland Biol Neoplasia 2005, 10:231-247.
13. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
14. Egeblad M., Rasch M.G., Weaver V.M. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 2010, 22:697-706.
15. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986, 315:1650-1659.
16. Hu M., Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genetics Dev 2008, 18:27-34.
17. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (New York, NY) 2004, 303:848-851.
18. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
19. Hu M., Peluffo G., Chen H., Gelman R., Schnitt S., Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci U S A 2009, 106:3372-3377.
20. Pyne N.J., Pyne S. Sphingosine 1-phosphate and cancer. Nat Rev Cancer 2010, 10:489-503.
21. Luga V., Zhang L., Viloria-Petit A.M., Ogunjimi A.A., Inanlou M.R., Chiu E., et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012, 151:1542-1556.
22. Singh A.B., Harris R.C. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 2005, 17:1183-1193.
23. Brachmann R., Lindquist P.B., Nagashima M., Kohr W., Lipari T., Napier M., et al. Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell 1989, 56:691-700.
24. Wong S.T., Winchell L.F., McCune B.K., Earp H.S., Teixido J., Massague J., et al. The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 1989, 56:495-506.
25. Anklesaria P., Teixido J., Laiho M., Pierce J.H., Greenberger J.S., Massague J. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci U S A 1990, 87:3289-3293.
26. Shi W., Fan H., Shum L., Derynck R. The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol 2000, 148:591-602.
27. Dallas S.L., Rosser J.L., Mundy G.R., Bonewald L.F. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 2002, 277:21352-21360.
28. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
29. Tatti O., Vehvilainen P., Lehti K., Keski-Oja J. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Exp Cell Res 2008, 314:2501-2514.
30. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
31. Roussos E.T., Condeelis J.S., Patsialou A. Chemotaxis in cancer. Nat Rev Cancer 2011, 11:573-587.
32. Wyckoff J., Wang W., Lin E.Y., Wang Y., Pixley F., Stanley E.R., et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64:7022-7029.
33. Giampieri S., Manning C., Hooper S., Jones L., Hill C.S., Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009, 11:1287-1296.
34. Rajaram M., Li J., Egeblad M., Powers R.S. System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity. PLoS Genetics 2013, 9:e1003789.
35. Hu M., Yao J., Carroll D.K., Weremowicz S., Chen H., Carrasco D., et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406.
36. Chaturvedi P., Gilkes D.M., Wong C.C., Luo W., Zhang H., Wei H., et al. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Investig 2013, 123:189-205.
37. Patsialou A., Wyckoff J., Wang Y., Goswami S., Stanley E.R., Condeelis J.S. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res 2009, 69:9498-9506.
38. Apostolopoulou M., Ligon L. Cadherin-23 mediates heterotypic cell-cell adhesion between breast cancer epithelial cells and fibroblasts. PloS One 2012, 7:e33289.
39. Roh-Johnson M., Bravo-Cordero J.J., Patsialou A., Sharma V.P., Guo P., Liu H., et al. Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation. Oncogene 2013, 10.1038/onc.2013.377.
40. Tamura D., Hiraga T., Myoui A., Yoshikawa H., Yoneda T. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol 2008, 33:17-24.
41. Friedl P., Locker J., Sahai E., Segall J.E. Classifying collective cancer cell invasion. Nat Cell Biol 2012, 14:777-783.
42. Bloom H.J., Richardson W.W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957, 11:359-377.
43. Contesso G., Mouriesse H., Friedman S., Genin J., Sarrazin D., Rouesse J. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 1987, 5:1378-1386.
44. Barton A.A. An electron microscope study of human breast cells in fibroadenosis and carcinoma. Br J Cancer 1964, 18:682-685.
45. Buehring G.C., Hackett A.J. Human breast tumor cell lines: identity evaluation by ultrastructure. J Natl Cancer Inst 1974, 53:621-629.
46. Cailleau R., Olive M., Cruciger Q.V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978, 14:911-915.
47. Engel L.W., Young N.A., Tralka T.S., Lippman M.E., O'Brien S.J., Joyce M.J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 1978, 38:3352-3364.
48. Gabbiani G., Kapanci Y., Barazzone P., Franke W.W. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol 1981, 104:206-216.
49. Keydar I., Chen L., Karby S., Weiss F.R., Delarea J., Radu M., et al. Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer (Oxford, England: 1990) 1979, 15:659-670.
50. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
51. Lu P., Takai K., Weaver V.M., Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor Persp Biol 2011, 3.
52. Willis A.L., Sabeh F., Li X.Y., Weiss S.J. Extracellular matrix determinants and the regulation of cancer cell invasion stratagems. J Microsc 2013, 251:250-260.
53. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Briand P., Damsky C., et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137:231-245.
54. Zhang K., Corsa C.A., Ponik S.M., Prior J.L., Piwnica-Worms D., Eliceiri K.W., et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol 2013, 15:677-687.
55. Wolf K., Te Lindert M., Krause M., Alexander S., Te Riet J., Willis A.L., et al. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J Cell Biol 2013, 201:1069-1084.
56. Haeger A., Krause M., Wolf K., Friedl P. Cell jamming: collective invasion of mesenchymal tumor cells imposed by tissue confinement. Biochim Biophys Acta 2014, 1840:2386-2395.
57. Tozluoglu M., Tournier A.L., Jenkins R.P., Hooper S., Bates P.A., Sahai E. Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nat Cell Biol 2013, 15:751-762.
58. Provenzano P.P., Eliceiri K.W., Campbell J.M., Inman D.R., White J.G., Keely P.J. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006, 4:38.
59. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
60. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12:954-961.
61. Herschkowitz J.I., Simin K., Weigman V.J., Mikaelian I., Usary J., Hu Z., et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007, 8:R76.
62. Pfefferle A.D., Herschkowitz J.I., Usary J., Harrell J.C., Spike B.T., Adams J.R., et al. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol. 2013, 14:R125.
63. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193:727-740.
64. Condeelis J., Segall J.E. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003, 3:921-930.
65. Alexander S., Koehl G.E., Hirschberg M., Geissler E.K., Friedl P. Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. Histochem Cell Biol 2008, 130:1147-1154.
66. Egeblad M., Ewald A.J., Askautrud H.A., Truitt M.L., Welm B.E., Bainbridge E., et al. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Disease Models Mech 2008, 1:155-167. discussion 65.
67. Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007, 7:737-749.
68. Cheung K.J., Gabrielson E., Werb Z., Ewald A.J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 2013, 155:1639-1651.
69. Nguyen-Ngoc K.V., Cheung K.J., Brenot A., Shamir E.R., Gray R.S., Hines W.C., et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A 2012, 109:E2595-E2604.
70. Dovas A., Patsialou A., Harney A.S., Condeelis J., Cox D. Imaging interactions between macrophages and tumour cells that are involved in metastasis in vivo and in vitro. J Microsc 2013, 251:261-269.
71. Ewald A.J. Isolation of mouse mammary organoids for long-term time-lapse imaging. Cold Spring Harbor Protoc 2013, 2013:130-133.
72. Fein M.R., Egeblad M. Caught in the act: revealing the metastatic process by live imaging. Disease Models Mech 2013, 6:580-593.
73. Entenberg D., Kedrin D., Wyckoff J., Sahai E., Condeelis J., Segall J.E. Imaging tumor cell movement in vivo. Curr Protoc Cell Biol 2013, Chapter 19:Unit19.7. 10.1002/0471143030.cb1907s58.
74. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9:265-273.
75. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
76. Tsai J.H., Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013, 27:2192-2206.
77. Kowalski P.J., Rubin M.A., Kleer C.G. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res: BCR 2003, 5:R217-R222.
78. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
79. Hennessy B.T., Gonzalez-Angulo A.M., Stemke-Hale K., Gilcrease M.Z., Krishnamurthy S., Lee J.S., et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009, 69:4116-4124.
80. Prat A., Parker J.S., Karginova O., Fan C., Livasy C., Herschkowitz J.I., et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res: BCR 2010, 12:R68.
81. Taube J.H., Herschkowitz J.I., Komurov K., Zhou A.Y., Gupta S., Yang J., et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 2010, 107:15449-15454.
82. Prat A., Karginova O., Parker J.S., Fan C., He X., Bixby L., et al. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Res Treat 2013, 142:237-255.
83. Prat A., Perou C.M. Deconstructing the molecular portraits of breast cancer. Mol Oncol 2011, 5:5-23.
84. Trimboli A.J., Fukino K., de Bruin A., Wei G., Shen L., Tanner S.M., et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 2008, 68:937-945.
85. Wicki A., Lehembre F., Wick N., Hantusch B., Kerjaschki D., Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006, 9:261-272.
86. McCaffrey L.M., Montalbano J., Mihai C., Macara I.G. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 2012, 22:601-614.
87. Xue B., Krishnamurthy K., Allred D.C., Muthuswamy S.K. Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion. Nat Cell Biol 2013, 15:189-200.
88. Shamir E.R., Pappalardo E., Jorgens D.M., Coutinho K., Tsai W.T., Aziz K., et al. Twist1-induced dissemination preserves epithelial identity and requires E-cadherin. J Cell Biol 2014, 204:839-856.
89. Glukhova M., Koteliansky V., Sastre X., Thiery J.P. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 1995, 146:706-716.
90. Moll R., Mitze M., Frixen U.H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993, 143:1731-1742.
91. Oka H., Shiozaki H., Kobayashi K., Inoue M., Tahara H., Kobayashi T., et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993, 53:1696-1701.
92. Rakha E.A., Abd El Rehim D., Pinder S.E., Lewis S.A., Ellis I.O. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 2005, 46:685-693.
93. Gould Rothberg B.E., Bracken M.B. E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis. Breast Cancer Res Treat 2006, 100:139-148.
94. Li C.I., Uribe D.J., Daling J.R. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005, 93:1046-1052.
95. Bertos N.R., Park M. Breast cancer-one term, many entities?. J Clin Investig 2011, 121:3789-3796.
96. Berx G., Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res: BCR 2001, 3:289-293.
97. Derksen P.W., Liu X., Saridin F., van der Gulden H., Zevenhoven J., Evers B., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10:437-449.
98. Bukholm I.K., Nesland J.M., Borresen-Dale A.L. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [see comments]. J Pathol 2000, 190:15-19.
99. Alpaugh M.L., Tomlinson J.S., Shao Z.M., Barsky S.H. A novel human xenograft model of inflammatory breast cancer. Cancer Res 1999, 59:5079-5084.
100. Colpaert C.G., Vermeulen P.B., Benoy I., Soubry A., van Roy F., van Beest P., et al. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br J Cancer 2003, 88:718-725.
101. Kleer C.G., van Golen K.L., Braun T., Merajver S.D. Persistent E-cadherin expression in inflammatory breast cancer. Modern Pathol 2001, 14:458-464.
102. Fernandez S.V., Robertson F.M., Pei J., Aburto-Chumpitaz L., Mu Z., Chu K., et al. Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Res Treat 2013, 140:23-33.
103. Friedl P., Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009, 10:445-457.
104. Friedl P., Noble P.B., Walton P.A., Laird D.W., Chauvin P.J., Tabah R.J., et al. Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res 1995, 55:4557-4560.
105. Hegerfeldt Y., Tusch M., Brocker E.B., Friedl P. Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Res 2002, 62:2125-2130.
106. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007, 9:1392-1400.
107. Dang T.T., Prechtl A.M., Pearson G.W. Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion. Cancer Res 2011, 71:6857-6866.
108. Calvo F., Ege N., Grande-Garcia A., Hooper S., Jenkins R.P., Chaudhry S.I., et al. Mechanotransduction and YAP-dependent matrix remodeling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol 2013, 15:637-646.
109. Matise L.A., Palmer T.D., Ashby W.J., Nashabi A., Chytil A., Aakre M., et al. Lack of transforming growth factor-beta signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Breast Cancer Res: BCR 2012, 14:R98.
110. Marusyk A., Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 2010, 1805:105-117.
111. Carey S.P., Starchenko A., McGregor A.L., Reinhart-King C.A. Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model. Clin Exp Metastasis 2013, 30:615-630.
112. Wolf K., Wu Y.I., Liu Y., Geiger J., Tam E., Overall C., et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007, 9:893-904.
113. Reffay M., Parrini M.C., Cochet-Escartin O., Ladoux B., Buguin A., Coscoy S., et al. Interplay of RhoA and mechanical forces in collective cell migration driven by leader cells. Nat Cell Biol 2014, 16:217-223.
114. Rorth P. Fellow travellers: emergent properties of collective cell migration. EMBO Rep 2012, 13:984-991.
115. Cheung W.K., Zhao M., Liu Z., Stevens L.E., Cao P.D., Fang J.E., et al. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell 2013, 23:725-738.
116. Govaere O., Komuta M., Berkers J., Spee B., Janssen C., de Luca F., et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut 2014, 63:674-685.
117. Pickup M.W., Laklai H., Acerbi I., Owens P., Gorska A.E., Chytil A., et al. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-beta-deficient mouse mammary carcinomas. Cancer Res 2013, 73:5336-5346.
118. Wang C.C., Bajikar S.S., Jamal L., Atkins K.A., Janes K.A. A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies. Nat Cell Biol 2014, 16:345-356.
119. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
120. Leek R.D., Landers R.J., Harris A.L., Lewis C.E. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999, 79:991-995.
121. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
122. Tsutsui S., Yasuda K., Suzuki K., Tahara K., Higashi H., Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005, 14:425-431.
123. Wyckoff J.B., Wang Y., Lin E.Y., Li J.F., Goswami S., Stanley E.R., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007, 67:2649-2656.
124. Guiet R., Van Goethem E., Cougoule C., Balor S., Valette A., Al Saati T., et al. The process of macrophage migration promotes matrix metalloproteinase-independent invasion by tumor cells. J Immunol (Baltimore, MD: 1950). 2011, 187:3806-3814.
125. Hagemann T., Robinson S.C., Schulz M., Trumper L., Balkwill F.R., Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004, 25:1543-1549.
126. Robinson B.D., Sica G.L., Liu Y.F., Rohan T.E., Gertler F.B., Condeelis J.S., et al. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 2009, 15:2433-2441.
127. DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16:91-102.
128. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194.
129. Gocheva V., Wang H.W., Gadea B.B., Shree T., Hunter K.E., Garfall A.L., et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 2010, 24:241-255.
130. Nozawa H., Chiu C., Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A 2006, 103:12493-12498.
131. Boyd N.F., Guo H., Martin L.J., Sun L., Stone J., Fishell E., et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007, 356:227-236.
132. McCormack V.A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prevention 2006, 15:1159-1169.
133. Wolfe J.N. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976, 37:2486-2492.
134. Pucci Minafra I., Luparello C., Sciarrino S., Tomasino R.M., Minafra S. Quantitative determination of collagen types present in the ductal infiltrating carcinoma of human mammary gland. Cell Biol Int Rep 1985, 9:291-296.
135. Li T., Sun L., Miller N., Nicklee T., Woo J., Hulse-Smith L., et al. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prevention 2005, 14:343-349.
136. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genetics 2003, 33:49-54.
137. Conklin M.W., Eickhoff J.C., Riching K.M., Pehlke C.A., Eliceiri K.W., Provenzano P.P., et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 2011, 178:1221-1232.
138. Provenzano P.P., Inman D.R., Eliceiri K.W., Knittel J.G., Yan L., Rueden C.T., et al. Collagen density promotes mammary tumor initiation and progression. BMC Med 2008, 6:11.
139. Lyons T.R., O'Brien J., Borges V.F., Conklin M.W., Keely P.J., Eliceiri K.W., et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011, 17:1109-1115.
140. Maller O., Hansen K.C., Lyons T.R., Acerbi I., Weaver V.M., Prekeris R., et al. Collagen architecture in pregnancy-induced protection from breast cancer. J Cell Sci 2013, 126:4108-4110.
141. Erler J.T., Bennewith K.L., Nicolau M., Dornhofer N., Kong C., Le Q.T., et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006, 440:1222-1226.
142. Calvo F., Ege N., Grande-Garcia A., Hooper S., Jenkins R.P., Chaudhry S.I., et al. Mechanotransduction and YAP-dependent matrix remodeling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol 2013, 15:637-646.
143. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
144. Elenbaas B., Weinberg R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001, 264:169-184.
145. Kauppila S., Stenback F., Risteli J., Jukkola A., Risteli L. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol 1998, 186:262-268.
146. Sabeh F., Li X.Y., Saunders T.L., Rowe R.G., Weiss S.J. Secreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion. J Biol Chem 2009, 284:23001-23011.
147. Yu M., Stott S., Toner M., Maheswaran S., Haber D.A. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011, 192:373-382.
148. Stott S.L., Hsu C.H., Tsukrov D.I., Yu M., Miyamoto D.T., Waltman B.A., et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 2010, 107:18392-18397.
149. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
150. Bissell M.J., Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1:46-54.
151. Cardiff R.D., Anver M.R., Gusterson B.A., Hennighausen L., Jensen R.A., Merino M.J., et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000, 19:968-988.
152. Jonkers J., Derksen P.W. Modeling metastatic breast cancer in mice. J Mammary Gland Biol Neoplasia 2007, 12:191-203.
153. Vargo-Gogola T., Rosen J.M. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007, 7:659-672.
154. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genetics Dev 2005, 15:87-96.